MedPath

Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle

Conditions
Germinal Cancers of the Testicle
Interventions
Genetic: Extraction of total RNA from healthy and tumour tissues
Registration Number
NCT02873793
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

By analogy with the mouse, the activity of control pathways for transposable elements (TE) in foetal primordial germinal cells could prove to be a determinant for fertility in adulthood in humans. Moreover, defects in the control of transposable elements (TE) could also contribute to the aetiology of germinal testicular cancer, by inducing chromosomal instability and tumorigenesis. In this context, the aim is to analyse a specific type of adult germinal testicular cancers, seminomas. Directly related to our research interest, the histological, transcriptomic and epigenetic features of theses adult tumours are reminiscent of germinal cells normally present in foetuses. The investigator postulates that these similarities could also extend to the biology of transposable elements (TE), and in particular to the initiation of the control of these elements. The management of seminomas requires surgery, orchiectomy, which consists of the total excision of the affected testicles. Using high-resolution high-throughput sequencing techniques, we propose to analyse the control pathways of transposable elements (TE) in tumour samples harvested from surgical pieces in comparison with adjacent healthy tissue. The results obtained in these tumour samples will be compared with those in normal foetal gonad samples.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  • men who have provided oral consent
  • men with germinal testicular cancer with negative or low serum markers (Alpha Foeto Protein AFP and Human Chorionic Gonadotrophin hCG), indicators of a seminomatous-type tumour
  • men who have undergone orchiectomy (total excision of the affected testicle)
  • confirmation of the diagnosis of seminomatous or non-seminomatous type by histology of the surgical piece
  • absence of hepatitis B or C or infection with human immunodeficiency virus (HIV).
Exclusion Criteria
  • men without national health insurance cover
  • Adults under guardianship

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
7/8 cases pure seminomasExtraction of total RNA from healthy and tumour tissues-
5 cases of non-seminomaExtraction of total RNA from healthy and tumour tissues-
3 cases of composite tumours seminoma/non-seminoma.Extraction of total RNA from healthy and tumour tissues-
Primary Outcome Measures
NameTimeMethod
The role of Transposable Element in tumorigenesis seminomas adultsthrough the study completion up to 36 months

Transcriptomic analysis of adult seminomas

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Dijon Bourgogne

🇫🇷

Dijon, France

© Copyright 2025. All Rights Reserved by MedPath